Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INNOVATE (VATE) Change in Accured Expenses: 2009-2025

Historic Change in Accured Expenses for INNOVATE (VATE) over the last 16 years, with Sep 2025 value amounting to $13.0 million.

  • INNOVATE's Change in Accured Expenses rose 400.00% to $13.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.7 million, marking a year-over-year increase of 252.02%. This contributed to the annual value of $12.2 million for FY2024, which is 208.93% up from last year.
  • According to the latest figures from Q3 2025, INNOVATE's Change in Accured Expenses is $13.0 million, which was down 35.64% from $20.2 million recorded in Q2 2025.
  • INNOVATE's Change in Accured Expenses' 5-year high stood at $32.7 million during Q3 2021, with a 5-year trough of -$27.9 million in Q2 2021.
  • Moreover, its 3-year median value for Change in Accured Expenses was $7.0 million (2023), whereas its average is $2.1 million.
  • In the last 5 years, INNOVATE's Change in Accured Expenses crashed by 494.44% in 2022 and then surged by 6,900.00% in 2023.
  • Quarterly analysis of 5 years shows INNOVATE's Change in Accured Expenses stood at $1.8 million in 2021, then tumbled by 494.44% to -$7.1 million in 2022, then crashed by 204.23% to -$21.6 million in 2023, then surged by 171.30% to $15.4 million in 2024, then skyrocketed by 400.00% to $13.0 million in 2025.
  • Its Change in Accured Expenses stands at $13.0 million for Q3 2025, versus $20.2 million for Q2 2025 and -$10.9 million for Q1 2025.